MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
16.27
-0.41 (-2.46%)
At close: Mar 20, 2026, 4:00 PM EDT
16.48
+0.21 (1.29%)
After-hours: Mar 20, 2026, 7:40 PM EDT

MLTX Statistics

Total Valuation

MLTX has a market cap or net worth of $1.17 billion. The enterprise value is $848.75 million.

Market Cap1.17B
Enterprise Value 848.75M

Important Dates

The next estimated earnings date is Monday, May 11, 2026, after market close.

Earnings Date May 11, 2026
Ex-Dividend Date n/a

Share Statistics

MLTX has 71.73 million shares outstanding. The number of shares has increased by 2.54% in one year.

Current Share Class 71.73M
Shares Outstanding 71.73M
Shares Change (YoY) +2.54%
Shares Change (QoQ) +7.26%
Owned by Insiders (%) 10.50%
Owned by Institutions (%) 41.56%
Float 35.48M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.81
P/TBV Ratio 3.83
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.27, with a Debt / Equity ratio of 0.25.

Current Ratio 9.27
Quick Ratio 8.77
Debt / Equity 0.25
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -33.78

Financial Efficiency

Return on equity (ROE) is -60.78% and return on invested capital (ROIC) is -36.59%.

Return on Equity (ROE) -60.78%
Return on Assets (ROA) -33.92%
Return on Invested Capital (ROIC) -36.59%
Return on Capital Employed (ROCE) -64.61%
Weighted Average Cost of Capital (WACC) 10.85%
Revenue Per Employee n/a
Profits Per Employee -$1.75M
Employee Count130
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, MLTX has paid $611,000 in taxes.

Income Tax 611,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -59.24% in the last 52 weeks. The beta is 1.24, so MLTX's price volatility has been higher than the market average.

Beta (5Y) 1.24
52-Week Price Change -59.24%
50-Day Moving Average 16.85
200-Day Moving Average 29.02
Relative Strength Index (RSI) 41.58
Average Volume (20 Days) 983,566

Short Selling Information

The latest short interest is 7.04 million, so 9.81% of the outstanding shares have been sold short.

Short Interest 7.04M
Short Previous Month 7.27M
Short % of Shares Out 9.81%
Short % of Float 19.83%
Short Ratio (days to cover) 5.19

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -244.83M
Pretax Income -229.71M
Net Income -227.32M
EBITDA -242.22M
EBIT -244.83M
Earnings Per Share (EPS) -$3.53
Full Income Statement

Balance Sheet

The company has $393.97 million in cash and $75.71 million in debt, with a net cash position of $318.26 million or $4.44 per share.

Cash & Cash Equivalents 393.97M
Total Debt 75.71M
Net Cash 318.26M
Net Cash Per Share $4.44
Equity (Book Value) 304.48M
Book Value Per Share 4.27
Working Capital 376.22M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$196.01 million and capital expenditures -$35,000, giving a free cash flow of -$196.04 million.

Operating Cash Flow -196.01M
Capital Expenditures -35,000
Depreciation & Amortization 2.62M
Net Borrowing 73.02M
Free Cash Flow -196.04M
FCF Per Share -$2.73
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MLTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.54%
Shareholder Yield -2.54%
Earnings Yield -19.48%
FCF Yield -16.80%

Analyst Forecast

The average price target for MLTX is $30.58, which is 87.95% higher than the current price. The consensus rating is "Buy".

Price Target $30.58
Price Target Difference 87.95%
Analyst Consensus Buy
Analyst Count 12
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1